Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention"deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California. more
Time Frame | RVPH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -44.44% | -3.39% | 0.2% |
1-Month Return | 10.24% | -1.92% | 2.72% |
3-Month Return | 9.37% | -10.54% | 7.31% |
6-Month Return | -3.45% | -4.47% | 10.44% |
1-Year Return | -60.67% | 4.06% | 27.53% |
3-Year Return | -51.56% | 0.94% | 30.88% |
5-Year Return | -86.62% | 36.67% | 89.21% |
10-Year Return | -85.58% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | - | 724.74K | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Profit | - | (724.74K) | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-72474000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 376.86K | 2.43M | 10.10M | 24.31M | 39.50T | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (376.86K) | (2.43M) | (10.10M) | (24.31M) | (39.50T) | [{"date":"2019-12-31","value":-37686000,"profit":false},{"date":"2020-12-31","value":-243465100,"profit":false},{"date":"2021-12-31","value":-1010451300,"profit":false},{"date":"2022-12-31","value":-2430660800,"profit":false},{"date":"2023-12-31","value":-3950363600000000,"profit":false}] |
Total Non-Operating Income/Expense | (938.34K) | (2.70M) | 1.59M | 170.90K | 39.50T | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (846.03K) | (3.78M) | (8.52M) | (24.32M) | (39.24M) | [{"date":"2019-12-31","value":-84603200,"profit":false},{"date":"2020-12-31","value":-378258800,"profit":false},{"date":"2021-12-31","value":-851587200,"profit":false},{"date":"2022-12-31","value":-2431851500,"profit":false},{"date":"2023-12-31","value":-3924388800,"profit":false}] |
Income Taxes | 800.00 | 800.00 | 6.00K | 20.78K | (16.95B) | [{"date":"2019-12-31","value":3.85,"profit":true},{"date":"2020-12-31","value":3.85,"profit":true},{"date":"2021-12-31","value":28.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-81575780.91,"profit":false}] |
Income After Taxes | (846.83K) | (3.78M) | (8.52M) | (24.34M) | 16.91B | [{"date":"2019-12-31","value":-0.01,"profit":false},{"date":"2020-12-31","value":-0.02,"profit":false},{"date":"2021-12-31","value":-0.05,"profit":false},{"date":"2022-12-31","value":-0.14,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | (846.83K) | (3.78M) | (8.52M) | (24.34M) | (39.26M) | [{"date":"2019-12-31","value":-84683200,"profit":false},{"date":"2020-12-31","value":-378338800,"profit":false},{"date":"2021-12-31","value":-852187600,"profit":false},{"date":"2022-12-31","value":-2433929200,"profit":false},{"date":"2023-12-31","value":-3926083700,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (846.83K) | (3.78M) | (8.52M) | (24.34M) | (39.26T) | [{"date":"2019-12-31","value":-84683200,"profit":false},{"date":"2020-12-31","value":-378338800,"profit":false},{"date":"2021-12-31","value":-852187600,"profit":false},{"date":"2022-12-31","value":-2433929200,"profit":false},{"date":"2023-12-31","value":-3926083700000000,"profit":false}] |
EPS (Diluted) | 0.42 | (0.31) | (0.56) | (1.25) | (1.64) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-73.81,"profit":false},{"date":"2021-12-31","value":-133.33,"profit":false},{"date":"2022-12-31","value":-297.62,"profit":false},{"date":"2023-12-31","value":-390.48,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
RVPH | |
---|---|
Cash Ratio | 0.32 |
Current Ratio | 0.39 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RVPH | |
---|---|
ROA (LTM) | -233.95% |
ROE (LTM) | -1795.06% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RVPH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.31 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.31 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RVPH | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 8.35 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Reviva Pharmaceuticals Holdings Inc. (RVPH) share price today is $1.546
Yes, Indians can buy shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) on Vested. To buy Reviva Pharmaceuticals Holdings Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RVPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) via the Vested app. You can start investing in Reviva Pharmaceuticals Holdings Inc. (RVPH) with a minimum investment of $1.
You can invest in shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) via Vested in three simple steps:
The 52-week high price of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $5.67. The 52-week low price of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $0.6.
The price-to-earnings (P/E) ratio of Reviva Pharmaceuticals Holdings Inc. (RVPH) is
The price-to-book (P/B) ratio of Reviva Pharmaceuticals Holdings Inc. (RVPH) is 8.35
The dividend yield of Reviva Pharmaceuticals Holdings Inc. (RVPH) is 0.00%
The market capitalization of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $46.82M
The stock symbol (or ticker) of Reviva Pharmaceuticals Holdings Inc. is RVPH